rifapentine

CHEBI:CHEBI_45304

Chemical Information

Molecular Formula
C47H64N4O12
Molecular Mass
877.03082
Charge
0
SMILES
CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)c(\C=N\N1CCN(CC1)C1CCCC1)c(O)c4c3C2=O
InChI
InChI=1S/C47H64N4O12/c1-24-13-12-14-25(2)46(59)49-37-32(23-48-51-20-18-50(19-21-51)31-15-10-11-16-31)41(56)34-35(42(37)57)40(55)29(6)44-36(34)45(58)47(8,63-44)61-22-17-33(60-9)26(3)43(62-30(7)52)28(5)39(54)27(4)38(24)53/h12-14,17,22-24,26-28,31,33,38-39,43,53-57H,10-11,15-16,18-21H2,1-9H3,(H,49,59)/b13-12+,22-17+,25-14-,48-23+/t24-,26+,27+,28+,33-,38-,39+,43+,47-/m0/s1
InChIKey
WDZCUPBHRAEYDL-GZAUEHORSA-N

Alternative Names

  • 3-(((4-Cyclopentyl-1-piperazinyl)imino)methyl)rifamycin
  • Cyclopentylrifampicin
  • Priftin (TN)
  • Rifapentine
  • (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-{(E)-[(4-cyclopentylpiperazin-1-yl)imino]methyl}-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1(4,7).0(5,28)]triaconta-1(28),1(29),2,4,9,19,21,25,27-nonaen-13-yl acetate

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:45304
DRON_00010000
35617
oboInOwl#hasDbXref
Wikipedia:Rifapentine

Additional References

Wikipedia:Rifapentine

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

core#notation
CHEBI:45304
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
35617
oboInOwl#hasDbXref
Wikipedia:Rifapentine
oboInOwl#hasAlternativeId
CHEBI:8861
oboInOwl#id
CHEBI:45304
generic_name
Rifapentine
rxcui
261101
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20241231
route
ORAL
dosage_form
POWDER
active_ingredient_strength
1 kg/kg
marketing_start_date
20170208
package_marketing_start_date
20170208
labeler_name
sanofi-aventis U.S. LLC
manufacturer_name
sanofi-aventis U.S. LLC
nui
N0000175501
pharm_class
Rifamycin Antimycobacterial [EPC]
pharm_class_cs
Rifamycins [CS]
brand_name
Priftin
brand_name_base
Priftin
product_ndc
53002-1718
application_number
NDA021024
spl_id
8b10a036-c487-4ec7-a7bf-460bce7d2bd7
active_ingredient_name
RIFAPENTINE
package_ndc
53002-1718-1
package_description
3 BLISTER PACK in 1 CARTON (53002-1718-1) / 8 TABLET, FILM COATED in 1 BLISTER PACK
unii
XJM390A33U
spl_set_id
c3882444-18ca-4708-a51b-6c089664c10c
pharm_class_epc
Rifamycin Antimycobacterial [EPC]
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_35816
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_13282
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect24516
owl#annotatedSource
t221385
owl#someValuesFrom
t733856